|
|
|
Volumn 24, Issue 2, 2002, Pages 227-278
|
|
Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
BIODIVERSITY;
BIOTECHNOLOGY;
COMMERCIAL PHENOMENA;
DEVELOPED COUNTRY;
DEVELOPING COUNTRY;
DRUG COST;
DRUG INDUSTRY;
ECONOMICS;
GENETICS;
HEALTH;
HEALTH CARE AND PUBLIC HEALTH;
HEALTH CARE DELIVERY;
HUMAN;
INTERNATIONAL COOPERATION;
LEGAL APPROACH;
LEGAL ASPECT;
LICENSING;
MEDICINAL PLANT;
MEDICOLEGAL ASPECT;
PATENT;
SOCIAL JUSTICE;
SOUTH AFRICA;
UNITED STATES;
HEALTH CARE AND PUBLIC HEALTH;
LEGAL APPROACH;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-RETROVIRAL AGENTS;
BIODIVERSITY;
BIOTECHNOLOGY;
COMMERCE;
DEVELOPED COUNTRIES;
DEVELOPING COUNTRIES;
DRUG COSTS;
DRUG INDUSTRY;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
INTELLECTUAL PROPERTY;
INTERNATIONAL COOPERATION;
LEGISLATION, MEDICAL;
LICENSURE;
PATENTS;
PLANTS, MEDICINAL;
SOCIAL JUSTICE;
SOUTH AFRICA;
UNITED STATES;
WORLD HEALTH;
|
|
EID: 0141876129
PISSN: 01941879
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
